Healthcare Facilities company Krishna Institute of Medical Sciences announced Q4FY24 & FY24 results: Gross revenue at Rs 6376 million, an increase of 9.8% on YoY and 4.7% on QoQ basis. EBITDA of Rs 1628 million, a decline of 3.2% on YoY and growth by 8.3% on QoQ basis. EBITDA margin in Q4FY24 stood at 25.5% vs. 28.9% in Q4 FY23 and 24.7% in Q3 FY24. EBITDA (excluding Other Income) Margin stands at 25.1%, showing a decline of 3.2% on YoY and an increase of 0.8% on QoQ. PAT at Rs 716 million in Q4FY24 against Rs 987 million and Rs 767 million in Q4 FY23 and Q3 FY24 respectively. Consolidated EPS declined by 29.8% on YoY and 8.8% on QoQ basis to Rs 8 Bed occupancy in Q4FY24 at 51.4%*, a decline by 1.7% on YoY and 2.8% QoQ basis. [*As per the industry standard, % occupancy is mentioned as % to bed capacity, rather than % to census beds, from this quarter] Cash and Cash Equivalents at Rs 132 crore as at 31st March, 2024. Net Debt to Equity ratio at 0.44 Announcing Q4 results, Dr. B Bhaskar Rao, CMD, KIMS Hospitals, said: Over all FY 24 has been a clinically and financially a good year for us. I am particularly pleased that our newly acquired units of Sunshine and Nagpur have shown good momentum. I am confident that FY25 will see robust growth with our new unit coming up at Nashik in Q1FY25 & Thane and Bangalore units getting operationalized by the end of FY25” Result PDF
Conference Call with Krishna Institute of Medical Sciences Management and Analysts on Q4FY24 Performance and Outlook. Listen to the full earnings transcript.